Clinical Trial Update: Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder [NA]

View source ↗

Summary

A clinical trial is investigating ketosis as a way to modulate metabolic pathways in bipolar disorder, and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: Stony Brook University | Conditions: Bipolar Disorder, Bipolar Disorder Type 1 | NA | Status: RECRUITING